Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN, OTCQB:KHRNF, Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that, after a successful first year in the Colombian market, the Company adds another significant milestone: its first import of Kuida cosmetic products into the United States. With this first shipment complete, Kuida has become the first Colombian brand to introduce legal CBD products in the US market.

Kuida has unveiled a new campaign, titled “We Do it Different,” featuring jewelry designer Daniela Salcedo, writer Amalia Andrade and news anchor Jessica de la Peña as brand ambassadors. (CNW Group/Khiron Life Sciences Corp.)

Launched initially in October 2018, the Kuida brand includes a pioneering line of CBD skincare, which were the first such products in Colombia to include CBD as an ingredient. Since then, the Company has built on its trail-blazing launch with a series of milestone achievements. Highlights include:

Entry into International Markets

  • Upon completion of its first shipment of Kuida product earlier this month, the Company has officially entered the U.S. skincare market, valued at $20 billion USD in 2018. The launch and first sales of product are expected for November 2019.
  • The Company also recently announced that it has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida products. The Company will begin with import and marketing in the UK, with first sales expected in Q1 2020, before a planned expansion to Spain, Germany and the broader European market, subject to the specific requirements of individual member states and TSXV approval.

Growing Distribution Network, with 300+ Points-of-Sale

  • Kuida is currently available in Colombia nationwide, with an established and growing distribution network of prominent national retailers and significant e-commerce platforms, including Farmatodo, Fedco, Linio, and Droguerias Cafam.
  • In addition to previously announced distribution agreements, Khiron continues to expand its presence in all regions in Colombia through new partnerships with four prominent retailers in Colombia. Providing an additional 42 points-of-sale, the latest distribution agreements further include expansion potential to 700 stores.

Expanded Portfolio and Strong Marketing Campaign for the New Year

  • Aiming to provide consumers with a comprehensive selection of CBD skincare, the Company received approval from INVIMA, Colombia’s health agency, in September 2019 to commercialize three additional Kuida CBD skin care products. Sales of the newly approved products are expected in Q4 2019.
  • Kuida has participated in high-profile and highly selective events across Colombia, the US and Europe, including Cosmoprof Worldwide Bologna, FounderMade East, Cosmoprof North America, and Salud y Belleza Colombia. In March 2020, Kuida will be prominently featured at Cosmoprof Worldwide Bologna, reaching over 265,000 global attendees and buyers.
  • Launching last month at Salud y Belleza 2019, Kuida has unveiled a new campaign, titled “We Do it Different.” Jewelry designer Daniela Salcedo, writer Amalia Andrade and news anchor Jessica de la Peña have joined Kuida as brand ambassadors, working with the brand to educate consumers on CBD and to inspire women to take ownership of their own personal care. Together, through their combined social media following, Kuida’s message of “We Do it Different” will reach over 1.4 million women and consumers.

Elsa Navarro, Skin Unit Director of Khiron Life Sciences, commented, “When Kuida launched last year, it became the first brand of its kind in Colombia to bring the benefits of CBD to a comprehensive line of skin and personal care products. But our leadership in the market goes beyond that – we were also the first licence holder in Colombia to educate on the use of CBD on skin through mass media, billboards, TV commercials and pop-up stores. We have built a diverse customer base, established a robust distribution network, and set the standard for sophisticated, safe CBD products in the Latin American market. Looking forward, we expect another exciting, successful year ahead as we introduce our brand to the US and European markets.”

About Khiron Life Sciences Corp.

Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The company delivers best in class regulatory compliance, has the first approved set of CBD cosmetic products on shelf in Colombia, and is currently facilitating testing to meet and surpass all license requirements for commercial cannabis derived products.

With a focused regional strategy and patient oriented approach, the Company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced executive team, and a knowledgeable Board of Directors that includes former President of Mexico, Vicente Fox.

Cautionary Notes

Forward-Looking Statements

This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Khiron undertakes no obligation to comment analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statement has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron’s control, including the risk factors discussed in Khiron’s Annual Information Form which is available on Khiron’s SEDAR profile at The forward-looking information contained in this press release is expressly qualified by this cautionary statement and are made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

United States Disclaimer

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United Statesor to U.S. Persons (as such term is defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Click here to connect with Khiron Life Sciences Corp. (TSXV:KHRN, OTC:KHRNF) for an Investor Presentation.



Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event:

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less